彭楚明,肖琴,陈友林,苏咏.静脉注射不同剂量免疫球蛋白治疗川崎病的临床疗效观察.[J].中南医学科学杂志.,2001,(6):581-583.
静脉注射不同剂量免疫球蛋白治疗川崎病的临床疗效观察
A Study on Different Dose of Intravenous Immuneglobulins for Treating Kawasaki Disease
  修订日期:2001-06-17
DOI:
中文关键词:  川崎病,免疫球蛋白,阿斯匹林
英文关键词:mucocutaneous lymph node syndrome,intravenous immuneglobulins,aspirin
基金项目:
彭楚明  肖琴  陈友林  苏咏
湖南省湘潭市韶山医院儿科 湖南湘潭411300 (彭楚明,肖琴,陈友林)
,湖南省湘潭市韶山医院儿科 湖南湘潭411300(苏咏)
摘要点击次数: 804
全文下载次数: 0
中文摘要:
      目的 观察不同剂量免疫球蛋白对川崎病 (KD)的治疗效果。方法  2 2例KD患儿给予中等剂量免疫球蛋白 (1g/kg)联用阿斯匹林治疗 ,另外 2 0例KD患儿给予大剂量免疫球蛋白 (2g/kg)联用阿斯匹林治疗。结果 两组病人治疗后临床表现持续的时间和血沉、C反应蛋白、血小板计数、心电图检查恢复正常的时间没有显著差异 (P >0 .0 5 ) ,中等剂量组 6例冠状动脉扩张和大剂量组 5例冠状动脉扩张治疗后均恢复正常。结论 免疫球蛋白 1g/kg或免疫球蛋白 2g/kg联用阿斯匹林治疗KD疗效相同 ,但中等剂量价廉且潜在的不良反应少
英文摘要:
      Objective:To observe the effect of different dose intravenous immuneglobulins(IVIG) for treating Kawasaki disease(KD). Methods: Twenty-two cases were treated with mediate dose of IVIG(1g/kg)and aspirin(ASA), the others with high dose of IVIG (2g/kg) and ASA. The effects of two groups were compared. Results: No difference between groups were observed on the lasting time of clinical manifestations and the recovering time of ESR?CRP?BPC and ECG(P>0.05).Six cases with coronary artery dilatation(CAD) in mediate dose group and five cases in high dose group were recovery after treatment. Conclusion:Both mediate dose of IVIG(1g/kg) and high dose of IVIG (2g/kg)for treating KD was same effective, but the therapy of mediate dose of IVIG was cheaper and the potential side effect of mediate dose of IVIG was less.
查看全文  查看/发表评论  下载PDF阅读器
关闭
function PdfOpen(url){ var win="toolbar=no,location=no,directories=no,status=yes,menubar=yes,scrollbars=yes,resizable=yes"; window.open(url,"",win); } function openWin(url,w,h){ var win="toolbar=no,location=no,directories=no,status=no,menubar=no,scrollbars=yes,resizable=no,width=" + w + ",height=" + h; controlWindow=window.open(url,"",win); } &et=C64C6BFA83D33783422CD1453A1A87F7FED3363AD1E767AC55134B710EE0C48EA51E9B1B6BA499FFBD26D6D1D1DD0BDE53F8A2C999D18BDBFEFB7558CC0F4882656041852BFFE0DBDCEDB635F38DF4D08BD744F81C01F6598CD9135C118134C3EC9737E1CCFA7984&pcid=A9DB1C13C87CE289EA38239A9433C9DC&cid=BB33F1C95224820A&jid=6A20DF2A798996E24F064D5ECF83A153&yid=14E7EF987E4155E6&aid=3608900&vid=&iid=B31275AF3241DB2D&sid=93ADA2AA3F969E58&eid=7882A2973AA04DE8&fileno=200106457&flag=1&is_more=0">